UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 269.

A

Aleong, IC; Bates, AW; Baithun, SI; (2000) Secondary neoplasms of the kidney: a clinico-pathological review of 443 cases. J PATHOL , 190 42A - 42A.

Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; (2000) Cell differentiation - Hepatocytes from nonhepatic adult stem cells. NATURE , 406 (6793) 257 - 257.

Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; (2000) Hepatocytes from non-hepatic adult stem cells. Nature , 406 (6793) 257-. 10.1038/35018642.

Alison, MR; Poulsom, R; Jeffrey, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; (2000) Plasticity of human haemopoietic stem cells: Differentiation to hepatocytes after liver and bone marrow transplantation. J PATHOL , 192 2A - 2A.

Allford, SL; Harrison, P; Lawrie, AS; Cohen, H; Mackie, IJ; Machin, SJ; (2000) Recurrent thrombotic thrombocytopenic purpura: Association of durable remission with cyclosporin and recovery in vWF-cleaving protease activity. Presented at: UNSPECIFIED.

Allford, SL; Harrison, P; Lawrie, AS; Liesner, R; Mackie, IJ; Machin, SJ; (2000) von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 111 (4) 1215 - 1222.

Anagnostopoulos, I; Hansmann, ML; Franssila, K; Harris, M; Harris, NL; Jaffe, ES; Han, J; (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood , 96 (5) pp. 1889-1899.

Ancliff, PJ; Davies, EG; Hann, IM; Hassan, A; Chessells, JM; (2000) Immunoregulatory disorders in association with myelodysplasia in childhood. LEUKEMIA , 14 (5) p. 967.

Anderson, FM; O'Hare, CC; Hartley, JA; Robins, DJ; (2000) Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents. ANTI-CANCER DRUG DES , 15 (2) 119 - 126.

Anthony, A; Pounder, RE; Dhillon, AP; Wakefield, AJ; Inflammatory Bowel Disease Study G, ; (2000) Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat. ALIMENT PHARM THER , 14 (2) 241 - 245.

Anthony, A; Sim, R; Dhillon, AP; Pounder, RE; Wakefield, AJ; (2000) Granulomatous vasculitis in Crohn's disease: Associated with the extra-mural vasculature. GASTROENTEROLOGY , 118 (4) A340 - A340.

Anthony, A; Sim, R; Guillaume, JL; Strosberg, AD; Dhillon, AP; Pounder, RE; Wakefield, AJ; (2000) Beta(beta)(3)-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells. ALIMENT PHARM THERAP , 14 (5) 579 - 585.

Ardeshna, KM; Corney, CP; Ings, SJ; Watts, MJ; Linch, DC; Devereux, S; (2000) A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34(+) progenitors. VOX SANG , 79 (1) 46 - 52.

Ardeshna, KM; Pizzey, AR; Devereaux, S; Khwaja, A; (2000) The PI3 kinase, p38 SAP kinase, and NF-kappa B signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. BLOOD , 96 (3) 1039 - 1046.

Ardeshna, KM; Pizzey, AR; Thomas, NSB; Orr, S; Linch, DC; Devereux, S; (2000) Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction. BRIT J HAEMATOL , 108 (4) 817 - 824.

Arguello, JR; Madrigal, JA; (2000) DNA conformational analysis. In: Bidwell, J and Navarette, C, (eds.) Histocompatibility Testing. (pp. 247-266). Imperial College Press: UK.

Ariad, S; Benharroch, D; Lupu, L; Davidovici, B; Dupin, N; Boshoff, C; (2000) Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient. ARCH PATHOL LAB MED , 124 (5) 753 - 755.

Arkenau, HT; Lüthi, U; (2000) [Amyloidoma]. Schweiz Med Wochenschr , 130 (35) 1244-.

Arostegui, JI; Gallardo, D; Rodriguez-Luaces, M; Querol, S; Madrigal, JA; Garcia-Lopez, J; Granena, A; (2000) Genomic typing of minor histocompatibility antigen HA-1 by reference strand mediated conformation analysis (RSCA). Tissue Antigens , 56 pp. 69-76.

Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Endicott, JA; Garman, EF; Gibson, AE; (2000) Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J MED CHEM , 43 (15) 2797 - 2804.

B

Barlow, HC; Bowman, KJ; Curtin, NJ; Calvert, AH; Golding, BT; Huang, B; Loughlin, PJ; (2000) Resistance-modifying agents. Part 7: 2, 6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha(1)-acid glycoprotein (AGP). BIOORG MED CHEM LETT , 10 (6) 585 - 589.

Bates, AW; (2000) Birth defects described in Elizabethan ballads. J ROY SOC MED , 93 (4) 202 - 207.

Bates, AW; Baithun, SI; (2000) Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. HISTOPATHOLOGY , 36 (1) 32 - 40.

Bates, AW; Feakins, RM; Scheimberg, I; (2000) Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis. HISTOPATHOLOGY , 37 (4) 316 - 322.

Bates, AW; Norton, AJ; Baithun, SI; (2000) Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. J CLIN PATHOL , 53 (6) 458 - 461.

Baynes, KCR; Beeton, CA; Panayotou, G; Stein, R; Soos, M; Hansen, T; Simpson, H; (2000) Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity. DIABETOLOGIA , 43 (3) pp. 321-331. 10.1007/s001250050050.

Beck, S; Trowsdale, J; (2000) The human major histocompatibility complex: Lessons from the DNA sequence. ANNU REV GENOM HUM G , 1 117 - 137.

Bench, AJ; Nacheva, EP; Hood, TL; Holden, JL; French, L; Swanton, S; Champion, KM; (2000) Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene , 19 (34) pp. 3902-3913. 10.1038/sj.onc.1203728.

Bench, AJ; Nacheva, EP; Hood, TL; Holden, JL; French, L; Swanton, S; Champion, KM; (2000) Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. ONCOGENE , 19 (34) 3902 - 3913.

Bhatia, J; Sharma, SK; Chester, KA; Pedley, RB; Boden, RW; Read, DA; Boxer, GM; (2000) Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein. Int J Cancer , 85 (4) pp. 571-577.

Boehm, MK; Corper, AL; Wan, T; Sohi, MK; Sutton, BJ; Thornton, JD; Keep, PA; (2000) Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts. Biochem J , 346 Pt pp. 519-528.

Bogunia-Kubik, K; Perez-Cruz, I; Fallen, PR; Madrigal, JA; Cohen, SBA; (2000) Cord blood lymphocytes have a low frequency of cytokine producing T cells due to a high threshold for activation. IMMUNOL LETT , 72 (3) pp. 145-146.

Borthwick, NJ; Lowdell, M; Salmon, M; Akbar, AN; (2000) Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type IIFN, and increases susceptibility to activation-induced apoptosis. INT IMMUNOL , 12 (7) 1005 - 1013.

Boshoff, C; (2000) Kaposi's sarcoma herpesvirus: from cell biology to pathogenesis. AIDS , 14 S5 - S5.

Botchway, ANS; Flores, NA; Sheridan, DJ; Cohen, H; (2000) Storage pool defect in pooled huffy coat platelet concentrates within the shelf-life period. CLIN LAB HAEMATOL , 22 (1) 21 - 27.

Broadstock, M; Michie, S; Gray, J; Mackay, J; Marteau, TM; (2000) The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer - A pilot study. PSYCHO-ONCOL , 9 (6) 537 - 548.

Brooks, N; McHugh, PJ; Lee, M; Hartley, JA; (2000) Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove. CHEM BIOL , 7 (9) 659 - 668.

C

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose Indium-III Octreotide therapy for disseminated carcinoid tumour. Gastroenterology , 118 (4 Supp) AGA-.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose indium-111 octreotide therapy for disseminated carcinoid tumour. GUT , 46 A74 - A74.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose indium-III octreotide therapy for disseminated carcinoid tumor. Gastroenterology , 118 (4) 2751-.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose indium-III octreotide therapy for disseminated carcinoid tumor. GASTROENTEROLOGY , 118 (4) A516 - A516.

Carmichael, J; Conron, M; Beynon, H; Crow, J; Warner, TT; (2000) Churg-Strauss syndrome presenting with visual loss. RHEUMATOLOGY , 39 (12) 1433 - 1434.

Cerone, MA; Marchetti, A; Bossi, G; Blandino, G; Sacchi, A; Soddu, S; (2000) p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death Differ , 7 (5) pp. 506-508. 10.1038/sj.cdd.4400676.

Chatterjee, R; Andrews, HO; McGarrigle, HH; Kottaridis, PD; Lees, WR; Mackinnon, S; Ralph, DJ; (2000) Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemoradiotherapy for haematological malignancies. BONE MARROW TRANSPL , 25 (11) 1185 - 1189.

Chatterjee, R; Kottaridis, PD; Lees, WR; Ralph, DJ; Goldstone, AH; (2000) Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myeloma. LANCET LTD

Chester, KA; Bhatia, J; Boxer, G; Cooke, SP; Flynn, AA; Huhalov, A; Mayer, A; (2000) Clinical applications of phage-derived sFvs and sFv fusion proteins. DISEASE MARKERS , 16 (1-2) 53 - 62.

Chester, KA; Mayer, A; Bhatia, J; Robson, L; Spencer, DI; Cooke, SP; Flynn, AA; (2000) Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer. Cancer Chemother Pharmacol , 46 Sup S8-12.

Chester, KA; Mayer, A; Bhatia, J; Robson, L; Spencer, DIR; Cooke, SP; Flynn, AA; (2000) Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer. In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. (pp. S8 - S12). SPRINGER-VERLAG

Chilcott, IT; Margara, R; Cohen, H; Rai, R; Skull, J; Pickering, W; Regan, L; (2000) Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. FERTIL STERIL , 73 (3) 526 - 530.

Chopra, R; Eaton, JD; Grassi, A; Potter, M; Shaw, B; Salat, C; Neumeister, P; (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol , 111 (4) pp. 1122-1129.

Cirinna, M; Trotta, R; Salomoni, P; Kossev, P; Wasik, M; Perrotti, D; Calabretta, B; (2000) Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. BLOOD , 96 (12) 3915 - 3921.

Clark, R; Byatt, SA; Bennett, CF; Brama, M; Martineau, M; Moorman, AV; Roberts, K; (2000) Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. LEUKEMIA , 14 (2) pp. 241-246. 10.1038/sj.leu.2401654.

Codish, S; Abu-Shakra, M; Ariad, S; Zirkin, HJ; Yermiyahu, T; Dupin, N; Boshoff, C; (2000) Manifestations of three HHV-8-related diseases in an HIV-negative patient: Immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma. AM J HEMATOL , 65 (4) 310 - 314.

Codrington, R; O'Connor, HE; Jalali, GR; Carrara, P; Papaioannou, M; Hart, SM; Hoffbrand, AV; (2000) Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value. BRITISH JOURNAL OF HAEMATOLOGY , 111 (4) pp. 1071-1079. 10.1046/j.1365-2141.2000.02464.x.

Cohen, SB; Woolley, J; Bogunia-Kubik, K; Natarajan, P; Kotecha, R; Belaramani, L; Fallen, PR; (2000) Macrophage colony stimulating factor (M-CSF) within cord blood sera may be partially responsible for the reduced proliferation of cord blood T cells. European Cytokine Network , 11 (4) pp. 608-617.

Cohen, SBA; Gluckman, E; Rubinstein, P; Madrigal, JA; (2000) Cord Blood Characteristics: Role in Stem Cell Transplantation. Martin Dunitz: London.

Cohen, SBA; Morgan, CL; Perez-Cruz, I; Perandin, F; Martinez, B; Madrigal, JA; (2000) Cord blood serum does not increase lymphocyte responses in comparison to adult serum. HUM IMMUNOL , 61 pp. 111-114.

Corell, A; Pay, AL; Little, AM; Hoddinott, MA; Arguello, JR; Borton, M; Dunne, C; (2000) Reference strand mediated conformation analysis resolves HLB-DRB1 typing ambiguities when matching for unrelated bone marrow transplantation. TISSUE ANTIGENS , 56 (1) pp. 82-86. 10.1034/j.1399-0039.2000.560111.x.

Coulonval, K; Vandeput, F; Stein, RC; Kozma, SC; Lamy, F; Dumont, JE; (2000) Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochem J , 348 Pt pp. 351-358.

Cox, ST; Hossain, E; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*8202 identified in a Caucasoid potential bone marrow donor. Tissue Antigens , 56 (2) pp. 188-191.

Cox, ST; Little, AM; Madrigal, JA; Marsh, SGE; (2000) Sequence of HLA-A*0209 confirmed. IMMUNOGENETICS , 51 (6) pp. 489-490. 10.1007/s002510050648.

Cox, ST; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*4413 identified in a UK Caucasoid potential bone marrow donor. Tissue Antigens , 55 (2) pp. 185-187.

Cross, TG; Scheel-Toellner, D; Henriquez, NV; Deacon, E; Salmon, M; Lord, JM; (2000) Serine/threonine protein kinases and apoptosis. Exp Cell Res , 256 (1) pp. 34-41. 10.1006/excr.2000.4836.

D

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Wales, JKH; Hindmarsh, PC; (2000) Molecular genetics of septo-optic dysplasia. HORMONE RESEARCH , 53 26 - 33.

Davis, BA; Porter, JB; (2000) Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. BLOOD , 95 (4) 1229 - 1236.

De Silva, IU; McHugh, PJ; Clingen, PH; Hartley, JA; (2000) Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. MOL CELL BIOL , 20 (21) 7980 - 7990.

Delaney, CA; Wang, LZ; Kyle, S; White, AW; Calvert, AH; Curtin, NJ; Durkacz, BW; (2000) Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. CLIN CANCER RES , 6 (7) 2860 - 2867.

Demetris, A; Adams, D; Bellamy, C; Blakolmer, K; Clouston, A; Dhillon, AP; Fung, J; (2000) Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology , 31 (3) pp. 792-799. 10.1002/hep.510310337.

Demuth, I; Wlodarski, M; Tipping, AJ; Morgan, NV; de Winter, JP; Thiel, M; Grasl, S; (2000) Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9. EUR J HUM GENET , 8 (11) 861 - 868.

Dey, A; McCloskey, EV; Taube, T; Cox, R; Pande, KC; Ashford, RU; Forster, M; (2000) Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk. Osteoporos Int , 11 (11) pp. 953-958. 10.1007/s001980070034.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazratis, A; Hartley, JA; Butler, J; (2000) The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl esters. ANTI-CANCER DRUG DES , 15 (5) 347 - 359.

Diaz, RM; Bateman, A; Emiliusen, L; Fielding, A; Trono, D; Russell, SJ; Vile, RG; (2000) A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. GENE THERAPY , 7 (19) pp. 1656-1663. 10.1038/sj.gt.3301277.

Ding, GR; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2000) Increase in X-ray-induced mutations by exposure to magnetic field (60 Hz, 5 mT) in NF-kappaB-inhibited cells. Biochem Biophys Res Commun , 276 (1) pp. 238-243. 10.1006/bbrc.2000.3455.

Dodi, IA; Morgan, CL; Madrigal, JA; (2000) The significance of HLA matching in cord blood stem cell transplantation. In: Cohen, SBA and Gluckman, E and Rubinstein, P and Madrigal, JA, (eds.) Cord Blood Transplantation. (pp. 205-238). Martin Dunitz Ltd: London.

Donohoe, S; Kingdom, JCP; Mackie, IJ; Burrell, S; Quenby, S; Jauniaux, E; Machin, SJ; (2000) Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. THROMB HAEMOSTASIS , 84 (1) 32 - 38.

Duchesne, GM; Bolger, JJ; Griffiths, GO; Trevor Roberts, J; Graham, JD; Hoskin, PJ; Fossâ, SD; (2000) A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int J Radiat Oncol Biol Phys , 47 (2) pp. 379-388.

Duke, V; Kapoor, A; Gricks, C; Melo, J; Foroni, L; (2000) BCL10 deletions in haematological malignancies: a cloning artefact? BRITISH JOURNAL OF HAEMATOLOGY , 111 (4) pp. 1106-1108. 10.1046/j.1365-2141.2000.02447.x.

Dupin, N; Diss, TL; Kellam, P; Tulliez, M; Du, MQ; Sicard, D; Weiss, RA; (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. BLOOD , 95 (4) 1406 - 1412.

Dutt, N; Bates, AW; Baithun, SI; (2000) Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children. HISTOPATHOLOGY , 37 (4) 323 - 331.

E

Ehlers, A; Beck, S; Forbes, SA; Trowsdale, J; Volz, A; Younger, R; Ziegler, A; (2000) MHC-linked olfactory receptor loci exhibit polymorphism and contribute to extended HLA/OR-haplotypes. GENOME RES , 10 (12) 1968 - 1978.

Eisen, T; Boshoff, C; Mak, I; Sapunar, F; Vaughan, MM; Pyle, L; Johnston, SRD; (2000) Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. BRIT J CANCER , 82 (4) 812 - 817.

F

Falini, B; Fizzotti, M; Pucciarini, A; Bigerna, B; Marafioti, T; Gambacorta, M; Pacini, R; (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood , 95 (6) pp. 2084-2092.

Farquharson, MJ; Bagshaw, AP; Porter, JB; Abeysinghe, RD; (2000) The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload. PHYS MED BIOL , 45 (5) 1387 - 1396.

Fielding, AK; Chapel-Fernandes, S; Chadwick, MP; Bullough, FJ; Cosset, FL; Russell, SJ; (2000) A hyperfusogenic gibbon ape leukemia envelope glycoprotein: Targeting of a cytotoxic gene by ligand display. HUMAN GENE THERAPY , 11 (6) pp. 817-826. 10.1089/10430340050015437.

Fischer, G; Arguello, JR; Perez-Rodriguez, M; McWhinnie, A; Marsh, SGE; Travers, PJ; Madrigal, JA; (2000) Sequence-specific oligonucleotide probing for MICB alleles reveals associations with MICA and HLA-B. IMMUNOGENETICS , 51 (7) pp. 591-599. 10.1007/s002510000179.

Fischer, G; Perez-Rodriguez, M; Arguello, JR; Cox, ST; McWhinnie, A; Travers, PJ; Madrigal, JA; (2000) Three novel MICB alleles. Tissue Antigens , 55 (2) pp. 166-170.

Flanagan, AM; Sarma, U; Steward, CG; Vellodi, A; Horton, MA; (2000) Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: A new approach to investigating pathogenesis. J BONE MINER RES , 15 (2) 352 - 360.

Flores, NA; Botchway, ANS; Turner, MA; Cohen, H; Sheridan, DJ; (2000) Products of the platelet release reaction influence cardiac electrophysiology independently of platelet-platelet interactions. PLATELETS , 11 (7) 415 - 417.

Foss, HD; Marafioti, T; Stein, H; (2000) [Hodgkin lymphoma. Classification and pathogenesis]. Pathologe , 21 (2) pp. 113-123.

Foss, HD; Marafioti, T; Stein, H; (2000) [The many faces of anaplastic large cell lymphoma]. Pathologe , 21 (2) pp. 124-136.

Friedman, HS; Kerby, T; Calvert, H; (2000) Temozolomide and treatment of malignant glioma. CLIN CANCER RES , 6 (7) 2585 - 2597.

G

Gardiner, C; Mackie, IJ; Malia, RG; Jones, DW; Winter, M; Leeming, D; Taberner, DA; (2000) The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant. BRIT J HAEMATOL , 111 (4) 1230 - 1235.

Gibson, V; Anderson, RJ; Hartley, JA; McAdam, SR; Cairns, D; (2000) Anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcription. J PHARM PHARMACOL , 52 (6) 599 - 602.

Greaves, M; Cohen, H; Machin, SJ; Mackie, I; (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. BRIT J HAEMATOL , 109 (4) 704 - 715.

Greene, JN; Linch, DC; Miller, CB; (2000) Current treatments for infection in neutropenic patients with hematologic malignancy. Oncology (Williston Park) , 14 (8 Suppl ) pp. 31-34.

Gribble, S; Andrews, K; Williams, D; Tillett, A; Bloxham, D; Proffit, J; Hackbarth, M; (2000) Fluorescence in situ hybridization detection of two telomeres on the short arm of a derived chromosome 16 in an infant with thrombocytopenia. Cancer Genet Cytogenet , 120 (2) pp. 99-104.

Gribble, S; Bench, A; Huntly, B; Green, AR; Nacheva, EP; (2000) Molecular cytogenetics of polycythemia vera; Lack of occult rearrangements detectable by FISH mapping, CGH, and colour karyotyping. BLOOD , 96 (11) 742A - 742A.

Gribble, S; Philips, M; Andrews, K; Roberts, I; Morrison, L; Grace, CD; Green, AR; (2000) Chromosome segment 8q23-qter identified as a common region of overrepresentation in CML blast crisis; A study of 10 CML derived cell lines using CGH, colour karyotyping, chromosome band specific painting and FISH mapping. BLOOD , 96 (11) 740A - 740A.

Gribble, SM; Roberts, I; Grace, C; Andrews, KM; Green, AR; Nacheva, EP; (2000) Cytogenetics of the chronic myeloid leukemia-derived cell line K562: Karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization. In: CANCER GENET CYTOGEN. (pp. 1 - 8). ELSEVIER SCIENCE INC

Griffin, RJ; Arris, CE; Bleasdale, C; Boyle, FT; Calvert, AH; Curtin, NJ; Dalby, C; (2000) Resistance-modifying agents. 8. Inhibition of O-6-alkylguanine-DNA alkyltransferase by O-6-alkenyl-, O-6-cycloalkenyl-, and O-6-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O-6-(1-cyclopentenylmethyl)guanine. J MED CHEM , 43 (22) 4071 - 4083. 10.1021/jm000961o.

Groot De, NG; Otting, N; Watkins, DI; Doxiadis, GM; Arguello, R; Madrigal, JA; Bontrop, RE; (2000) MHC class I diversity in a West-African chimpanzee population: implications for HIV research. Immunogenetics , 51 pp. 398-409.

Guo, A; Salomoni, P; Luo, JY; Shih, A; Zhong, S; Gu, W; Pandolfi, PP; (2000) The function of PML in p53-dependent apoptosis. NAT CELL BIOL , 2 (10) 730 - 736.

H

Hackshaw, AK; Wald, NJ; (2000) Revised distribution parameters for serum markers for trisomy 18. J MED SCREEN , 7 (4) 215 - 215.

Hackshaw, AK; Wald, NJ; Michell, MJ; Field, S; Wilson, ARM; (2000) An investigation into why two-view mammography is better than one-view in breast cancer screening. CLIN RADIOL , 55 (6) 454 - 458.

Hansen, SH; Zegers, MMP; Woodrow, M; Rodriguez-Viciana, P; Chardin, P; Mostov, KE; McMahon, M; (2000) Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway. MOL CELL BIOL , 20 (24) 9364 - 9375.

Hargreaves, RHJ; Hartley, JA; Butler, J; (2000) Mechanisms of action of quinone-containing alkylating agents: DNA alkylation by aziridinylquinones. FRONT BIOSCI , 5 E172 - E180.

Harland, SJ; (2000) Conundrum of the hereditary component of testicular cancer. LANCET , 356 (9240) 1455 - 1456.

Hartley, JA; Hazrati, A; Kelland, LR; Khanim, R; Shipman, M; Suzenet, F; Walker, LF; (2000) A Synthetic Azinomycin Analogue with Demonstrated DNA Cross-Linking Activity: Insights into the Mechanism of Action of this Class of Antitumor Agent The authors gratefully acknowledge the financial support provided by the CRC and the EPSRC. We are indebted to the EPSRC National Mass Spectrometry Centre for performing mass spectral measurements, and the EPSRC Chemical Database Service at Daresbury.1. Angew Chem Int Ed Engl , 39 (19) pp. 3467-3470.

Harvey, CJ; Peniket, AJ; Miszkiel, K; Patterson, K; Goldstone, AH; Mackinnon, S; Hall-Craggs, MA; (2000) MR angiographic diagnosis of cerebral venous sinus thrombosis following allogeneic bone marrow transplantation. Bone Marrow Transplant , 25 (7) pp. 791-795. 10.1038/sj.bmt.1702238.

Helmberg, W; Hegland, J; Hurley, CK; Maiers, M; Marsh, SGE; Muller, C; Rozemuller, EH; (2000) Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. TISSUE ANTIGENS , 56 (1) pp. 99-102. 10.1034/j.1399-0039.2000.560115.x.

Hochhauser, D; (2000) Relevance of mitochondrial DNA in cancer. LANCET , 356 (9225) 181 - 182.

Hoddinott, MA; Cox, ST; McWhinnie, AJ; Marsh, SGE; Ogilvie, H; Madrigal, JA; Little, AM; (2000) A new allele, HLA-B*1555, identified in an African patient awaiting bone marrow transplantation. TISSUE ANTIGENS , 55 (5) pp. 463-466. 10.1034/j.1399-0039.2000.550512.x.

Hooshmand-Rad, R; Hájková, L; Klint, P; Karlsson, R; Vanhaesebroeck, B; Claesson-Welsh, L; Heldin, CH; (2000) The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci , 113 Pt pp. 207-214.

Hughes, AN; Griffin, MJ; Newell, DR; Calvert, AH; Johnston, A; Kerr, B; Lee, C; (2000) Clinical pharmacokinetic and in vitro combination studies of nolatrexed dihydrochloride (AG337, Thymitaq (TM)) and paclitaxel. BRIT J CANCER , 82 (9) 1519 - 1527.

J

Jackson, TR; Brown, FD; Nie, ZZ; Miura, K; Foroni, L; Sun, JL; Hsu, VW; (2000) ACAPs are Arf6 GTPase-activating proteins that function in the cell periphery. JOURNAL OF CELL BIOLOGY , 151 (3) pp. 627-638. 10.1083/jcb.151.3.627.

Jacob, JP; Milne, S; Beck, S; Kaufman, J; (2000) The major and a minor class II beta-chain (B-LB) gene flank the Tapasin gene in the B-F/B-L region of the chicken major histocompatibility complex. IMMUNOGENETICS , 51 (2) 138 - 147.

Jones, DW; Gallimore, MJ; Mackie, IJ; Harris, SL; Winter, M; (2000) Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. BRIT J HAEMATOL , 110 (3) 721 - 726.

K

Kelly, PF; Vandergriff, J; Nathwani, A; Nienhuis, AW; Vanin, EF; (2000) Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. BLOOD , 96 (4) 1206 - 1214.

Khakoo, SI; Ling, R; Scott, I; Dodi, AI; Harrison, TJ; Dusheiko, GM; Madrigal, JA; (2000) Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut , 47 (1) pp. 137-143.

Kinashi, T; Katagiri, K; Watanabe, S; Vanhaesebroeck, B; Downward, J; Takatsu, K; (2000) Distinct mechanisms of alpha 5beta 1 integrin activation by Ha-Ras and R-Ras. J Biol Chem , 275 (29) pp. 22590-22596. 10.1074/jbc.M000633200. Gold open access

Kottaridis, PD; Milligan, DW; Chopra, R; Chakraverty, RK; Chakrabarti, S; Robinson, S; Peggs, K; (2000) In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. BLOOD , 96 (7) 2419 - 2425.

Kottaridis, PD; Peggs, K; Devereux, S; Goldstone, AH; Mackinnon, S; (2000) Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation. HAEMATOLOGICA , 85 (10) 1116 - 1117. Gold open access

Kottaridis, PD; Peggs, K; Lawrence, A; Verfuerth, S; Chatterjee, R; Telfer, P; Porter, JB; (2000) One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and beta-thalassaemia major: potential cure of both marrow disorders. BONE MARROW TRANSPL , 25 (6) 677 - 678.

L

Langabeer, SE; Gale, RE; Walker, H; Linch, DC; (2000) Reported cryptic rearrangements of CBF beta-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA. LEUKEMIA , 14 (5) 944 - 945.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (2000) Effect of instruments on lupus anticoagulant testing - Rebuttal. THROMB HAEMOSTASIS , 83 (2) 346 - 348.

Ledermann, JA; (2000) High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer. INT J GYNECOL CANCER , 10 53 - 56.

Linch, DC; Gosden, RG; Tulandi, T; Tan, SL; Hancock, SL; (2000) Hodgkin's Lymphoma: Choice of Therapy and Late Complications. Hematology Am Soc Hematol Educ Program pp. 205-221. Gold open access

Linch, DC; Smith, P; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, D; (2000) A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma. Ann Oncol , 11 Sup pp. 87-90.

Lindh, M; Horal, P; Dhillon, AP; Norkrans, G; (2000) Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J VIRAL HEPATITIS , 7 (4) 258 - 267.

Lopez-Matas, M; Rodriguez-Justo, M; Morilla, R; Catovsky, D; Matutes, E; (2000) Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Haematologica , 85 (11) pp. 1140-1145.

Lowdell, MW; Koh, MBC; (2000) Immunotherapy of AML: future directions. J CLIN PATHOL , 53 (1) 49 - 54.

M

MacLean, AB; Reid, WMN; Rolfe, KJ; Gammell, SJ; Pugh, HEJ; Gatter, KC; Fong, ACWT; (2000) Role of angiogenesis in benign, premalignant and malignant vulvar lesions. JOURNAL OF REPRODUCTIVE MEDICINE , 45 (8) 609 - 612.

Macdonald, C; Walker, S; Watts, M; Ings, S; Linch, DC; Devereux, S; (2000) Effect of changes in expression of the amphotropic retroviral receptor PiT-2 on transduction efficiency and viral titer: Implications for gene therapy. HUM GENE THER , 11 (4) 587 - 595.

Mackinnon, S; (2000) Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation? BRIT J HAEMATOL , 110 (1) 12 - 17.

Madrigal, JA; Shaw, BE; Brookes, P; Potter, M; Prentice, HG; Goldman, JM; Little, AM; (2000) The genetic factors which affect the outcome of unrelated bone marrow transplantation. Blood , 96 (11) 1792-.

Maini, MK; Gudgeon, N; Wedderburn, LR; Rickinson, AB; Beverley, PCL; (2000) Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J IMMUNOL , 165 (10) 5729 - 5737.

Mallett, SV; Peachey, TD; Sanehi, O; Hazlehurst, G; Mehta, A; (2000) Reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. Anaesthesia , 55 (10) pp. 1013-1019.

Marafioti, T; Hummel, M; Foss, HD; Laumen, H; Korbjuhn, P; Anagnostopoulos, I; Lammert, H; (2000) Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood , 95 (4) pp. 1443-1450.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update April/May 2000. Hum Immunol , 61 (8) pp. 841-842.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update April/May 2000. WHO Nomenclature Committee for Factors of HLA System. Tissue Antigens , 56 (3) pp. 286-288.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update December 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (4) pp. 381-382.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update February 2000. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 61 (6) 630-.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update February 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (6) pp. 571-572.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update January 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (5) pp. 475-476.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update June 2000. WHO Nomenclature Committee for Factors of the HLA system. Hum Immunol , 61 (9) 950-.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update June 2000. WHO Nomenclature Committee for factor of HLA System. Tissue Antigens , 56 (3) pp. 289-290.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update March 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (1) pp. 103-104.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update October/November 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (2) pp. 191-194.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update October/November 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 61 (3) pp. 354-356.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update August 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (6) pp. 563-564.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update October 2000. Hum Immunol , 61 (12) pp. 1404-1405.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update September 2000. Hum Immunol , 61 (12) 1403-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update September 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (6) pp. 565-566.

Marsh, SGE; (2000) Nomenclature for factors of HLA system, update August 2000. HUMAN IMMUNOLOGY , 61 (10) pp. 1055-1056. 10.1016/S0198-8859(00)00204-4.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update April/May 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (4) pp. 251-252. 10.1046/j.1365-2370.2000.00229.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update December 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (2) p. 109. 10.1046/j.1365-2370.2000.00207.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update December 1999. HUMAN IMMUNOLOGY , 61 (4) pp. 425-426. 10.1016/S0198-8859(00)00102-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) p. 161. 10.1046/j.1365-2370.2000.00219.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update January 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) pp. 159-160. 10.1046/j.1365-2370.2000.00210.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update January 2000. HUMAN IMMUNOLOGY , 61 (5) pp. 528-529. 10.1016/S0198-8859(00)00116-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update July 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (5-6) pp. 433-434.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update July 2000. HUMAN IMMUNOLOGY , 61 (10) pp. 1053-1054. 10.1016/S0198-8859(00)00205-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update June 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (5-6) p. 431.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update March 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) p. 163. 10.1046/j.1365-2370.2000.00224.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update October/November 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (2) pp. 105-107. 10.1046/j.1365-2370.2000.00208.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update September 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (1) p. 55. 10.1046/j.1365-2370.2000.00201.x.

Mayer, A; Flynn, AA; Tsiompanou, E; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2000) Radioimmunotherapy is more effective in small tumours due to higher dose and dose rate. British Journal of Cancer , 83 16-.

Mayer, A; Flynn, AA; Tsiompanou, E; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2000) Radioimmunotherapy is more effective in small tumours due to higher dose and dose rate. In: BRIT J CANCER. (pp. 32 - 32). CHURCHILL LIVINGSTONE

Mayer, A; Shaw, J; 'Ath, SD; Price, P; Blesing, C; Corrie, P; (2000) A phase II study of gemcitabine and flutamide in advanced pancreatic cancer. BRITISH JOURNAL OF CANCER , 83 p. 18.

Mayer, A; Shaw, J; D'Ath, S; Price, P; Blesing, C; Corrie, P; (2000) Phase II study of gemcitabine and Flutamide in advanced pancreatic cancer. ANNALS OF ONCOLOGY , 11 p. 68.

Mayer, A; Tsiompanou, E; O'Malley, D; Boxer, GM; Bhatia, J; Flynn, AA; Chester, KA; (2000) Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody. CLIN CANCER RES , 6 (5) 1711 - 1719.

McGreavey, L; se, F; en, P; Ethel, M; Potter, M; Prentice, HG; nt, T; (2000) Analysis of reconstitution the T-cell compartment in patients undergoing stem cell transplantation. HUM IMMUNOL , 61 (Suppl) 497A-.

McHugh, PJ; Sones, WR; Hartley, JA; (2000) Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. MOL CELL BIOL , 20 (10) 3425 - 3433.

McMorrow, T; van den Wijngaard, A; Wollenschlaeger, A; van de Coreut, M; Monkhorst, M; Trimborn, T; Fraser, P; (2000) Activation of the beta globin locus by transcription factors and chromatin modifiers. EMBO J , 19 (18) 4986 - 4996.

Meja, KK; Seldon, PM; Nasuhara, Y; Ito, K; Barnes, PJ; Lindsay, MA; Giembycz, MA; (2000) p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Br J Pharmacol , 131 (6) pp. 1143-1153. 10.1038/sj.bjp.0703684.

Mestiri, S; Monastiri, K; Ben Ahmed, S; Bouaouina, N; Presneau, N; Bignon, YJ; Khairi, H; (2000) [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women]. Arch Inst Pasteur Tunis , 77 (1-4) pp. 11-15.

Meyer, T; Rustin, GJ; (2000) Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer , 82 (9) pp. 1535-1538. 10.1054/bjoc.2000.1174.

Mitjans, F; Meyer, T; Fittschen, C; Goodman, S; Jonczyk, A; Marshall, JF; Reyes, G; (2000) In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. Int J Cancer , 87 (5) pp. 716-723.

Mittnacht, S; Boshoff, C; (2000) Viral cyclins. REV MED VIROL , 10 (3) 175 - 184.

Miyakoshi, J; Mori, Y; Yaguchi, H; Ding, G; Fujimori, A; (2000) Suppression of heat-induced HSP-70 by simultaneous exposure to 50 mT magnetic field. Life Sci , 66 (13) pp. 1187-1196.

Miyakoshi, J; Yoshida, M; Yaguchi, H; Ding, GR; (2000) Exposure to extremely low frequency magnetic fields suppresses x-ray-induced transformation in mouse C3H10T1/2 cells. Biochem Biophys Res Commun , 271 (2) pp. 323-327. 10.1006/bbrc.2000.2635.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2000) Forum: journal club. Cytometry , 42 (6) pp. 394-395.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2000) Simplified flow cytometric method for fetal hemoglobin containing red blood cells. CYTOMETRY , 42 (6) 389 - 393.

Mungall, AJ; Beck, S; Cann, HM; Dunham, I; Trowsdale, J; Ziegler, A; (2000) Report of the Fourth International Chromosome 6 Workshop 1999. 10-12 June 1999. Cambridge, UK. Abstracts. Cytogenet Cell Genet , 88 (3-4) pp. 173-196.

Mutimer, D; Dusheiko, G; Barrett, C; Grellier, L; Ahmed, M; Anschuetz, G; Burroughs, A; (2000) Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up. TRANSPLANTATION , 70 (5) 809 - 815.

N

Nacheva, EP; Gribble, S; Andrews, K; Wienberg, J; Grace, CD; (2000) Screening for specific chromosome involvement in hematological malignancies using a set of seven chromosome painting probes - An alternative approach for chromosome analysis using standard FISH instrumentation. In: CANCER GENET CYTOGEN. (pp. 65 - 72). ELSEVIER SCIENCE INC

Napier, MP; Ledermann, JA; (2000) Novel chemotherapeutic agents in colorectal cancer. EUR J SURG ONCOL , 26 (6) 605 - 610. 10.1053/ejso.2000.0955.

Napier, MP; Ledermann, JA; (2000) Risk analysis in surgical oncology - Part I: Concepts and tools. European Journal of Surgical Oncology , 26 (6) pp. 599-604. 10.1053/ejso.2000.0954.

Napier, MP; Sharma, SK; Springer, CJ; Bagshawe, KD; Green, AJ; Martin, J; Stribbling, SM; (2000) Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma. Clin Cancer Res , 6 (3) pp. 765-772.

Nikitenko, LL; Lloyd, BH; Rudland, PS; Fear, S; Barraclough, R; (2000) Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. INT J CANCER , 86 (2) 219 - 228.

Nikitenko, LL; MacKenzie, IZ; Rees, MCP; Bicknell, R; (2000) Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. MOL HUM REPROD , 6 (9) 811 - 819.

Nitu-Whalley, IC; Lee, CA; Dhillon, AP; Mistry, PK; (2000) Management of liver failure in a hemophilic patient co-infected with human immunodeficiency and hepatitisC viruses. Review Series Hepatitis , 1 pp. 18-19.

Noble, KE; Harkness, D; Yong, KL; (2000) Interleukin 10 regulates cellular responses in monocyte/endothelial cell co-cultures. BRIT J HAEMATOL , 108 (3) 497 - 504.

O

Oksenhendler, E; Meignin, V; Dupin, N; Boshoff, C; Isaacson, PG; Clauvel, JP; (2000) High incidence of non-Hogkin's lymphoma (NHL) in HIV/HHV8 associated Castleman's disease (CD). J ACQ IMMUN DEF SYND , 23 (3) A24 - A24.

Oliveros, JC; Blaschke, C; Herrero, J; Dopazo, J; Valencia, A; (2000) Expression profiles and biological function. In: (pp. pp. 106-117).

P

Pavlidis, N; Aamdal, S; Awada, A; Calvert, H; Fumoleau, P; Sorio, R; Punt, C; (2000) Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG). CANCER CHEMOTH PHARM , 46 (2) 167 - 171.

Pearson, TC; Messinezy, M; Westwood, N; Green, AR; Bench, AJ; Green, AR; Huntly, BJ; (2000) A Polycythemia Vera Updated: Diagnosis, Pathobiology, and Treatment. Hematology Am Soc Hematol Educ Program pp. 51-68. Gold open access

Peggs, KS; Ings, SJ; Kottaridis, PD; Yong, K; Williams, CD; Goldstone, AH; Mackinnon, S; (2000) Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring. BLOOD , 96 (1) 369 - 370.

Peggs, KS; Preiser, W; Kottaridis, PD; McKeag, N; Brink, NS; Tedder, RS; Goldstone, AH; (2000) Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation. BRIT J HAEMATOL , 111 (3) 782 - 790.

Perez-Cruz, I; Fallen, P; Madrigal, JA; Cohen, SBA; (2000) Naive T cells from cord blood have the capacity to make Types 1 and 2 cytokines. IMMUNOL LETT , 75 (1) pp. 85-88.

Perez-Rodriguez, M; Corell, A; Arguello, JR; Cox, ST; McWhinnie, A; Marsh, SGE; Madrigal, JA; (2000) A new MICA allele with ten alanine residues in the exon 5 microsatellite. TISSUE ANTIGENS , 55 (2) pp. 162-165. 10.1034/j.1399-0039.2000.550209.x.

Pezzella, F; Munson, PJ; Miller, KD; Goldstone, AH; Gatter, KC; (2000) The diagnosis of low-grade peripheral B-cell neoplasms in bone marrow trephines. BRITISH JOURNAL OF HAEMATOLOGY , 108 (2) pp. 369-376.

Platt, GM; Cannell, E; Cuomo, ME; Singh, S; Mittnacht, S; (2000) Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines. Virology , 272 (2) pp. 257-266. 10.1006/viro.2000.0343.

Porrello, A; Cerone, MA; Coen, S; Gurtner, A; Fontemaggi, G; Cimino, L; Piaggio, G; (2000) p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol , 151 (6) pp. 1295-1304.

Q

Quaglia, AF; Blanco, GD; Greaves, R; Burroughs, AK; Dhillon, AP; (2000) Development of ductopaenic liver allograft rejection includes a "hepatitic" phase prior to duct loss. J HEPATOL , 33 (5) 773 - 780.

R

Radkov, SA; Kellam, P; Boshoff, C; (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. NAT MED , 6 (10) 1121 - 1127.

Ramon, D; Scott, I; Cox, ST; Pesoa, S; Vullo, C; Little, AM; Madrigal, JA; (2000) HLA-A*6817, identified in the Kolla Amerindians of North-West Argentina possesses a novel nucleotide substitution. Tissue Antigens , 55 (5) pp. 453-454.

Rioja, A; Pizzey, AR; Marson, CM; Thomas, NSB; (2000) Preferential induction of apoptosis of leukaemic cells by farnesol. FEBS LETT , 467 (2-3) 291 - 295.

Robertson, JD; Gale, RE; Wynn, RF; Dougal, M; Linch, DC; Testa, NG; Chopra, R; (2000) Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. BRIT J HAEMATOL , 109 (2) 272 - 279.

Robinson, J; Malik, A; Parham, P; Bodmer, JG; Marsh, SGE; (2000) IMGT/HLA Database - a sequence database for the human major histocompatibility complex. TISSUE ANTIGENS , 55 (3) pp. 280-287. 10.1034/j.1399-0039.2000.550314.x.

Robinson, J; Marsh, SG; (2000) The IMGT/HLA sequence database. Rev Immunogenet , 2 (4) pp. 518-531.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (2000) In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. BRIT J HAEMATOL , 108 (4) 859 - 864.

Robinson, MSC; Mackie, IJ; Machin, SJ; Harrison, P; (2000) Two colour analysis of reticulated platelets. CLIN LAB HAEMATOL , 22 (4) 211 - 213.

S

Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA; (2000) Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS , 14 (8) pp. 1001-1007.

Saifuddin, A; Whelan, J; Pringle, JAS; Cannon, SR; (2000) Malignant round cell tumours of bone: atypical clinical and imaging features. SKELETAL RADIOL , 29 (11) 646 - 651.

Salomoni, P; Condorelli, F; Sweeney, SM; Calabretta, B; (2000) Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects. BLOOD , 96 (2) 676 - 684.

Salomoni, P; Pandolfi, PP; (2000) Transcriptional regulation of cellular transformation. NAT MED , 6 (7) 742 - 744.

Salto-Tellez, M; Kocjan, G; (2000) Lymphocytic mastopathy in a patient with previous breast cancer diagnosed by fine-needle aspirate. DIAGN CYTOPATHOL , 23 (2) 141 - 142.

Salto-Tellez, M; Saunders, C; Kocjan, G; (2000) Diagnosis of multiple granular cell tumours by fine needle aspiration cytology. CYTOPATHOLOGY , 11 (3) 191 - 193.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. Gut , 46 (S2) W96-.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. Gastroenterology , 118 (4) 616-.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. GUT , 46 A56 - A56.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. GASTROENTEROLOGY , 118 (4) A86 - A86.

Seitz, V; Hummel, M; Marafioti, T; Anagnostopoulos, I; Assaf, C; Stein, H; (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood , 95 (10) pp. 3020-3024.

Sharp, TV; Boshoff, C; (2000) Kaposi's sarcoma-associated herpesvirus: From cell biology to pathogenesis. IUBMB LIFE , 49 (2) 97 - 104.

Shoab, SS; Porter, JB; Scurr, JH; Coleridge-Smith, PD; (2000) Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot study. J VASC SURG , 31 (3) 456 - 461.

Sinclair, PB; Nacheva, EP; Leversha, M; Telford, N; Chang, J; Reid, A; Bench, A; (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. In: BLOOD. (pp. 738 - 744). AMER SOC HEMATOLOGY

Sotlar, K; Marafioti, T; Griesser, H; Theil, J; Aepinus, C; Jaussi, R; Stein, H; (2000) Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. Mol Pathol , 53 (4) pp. 188-193.

Stammers, M; Rowen, L; Rhodes, D; Trowsdale, J; Beck, S; (2000) BTL-II: a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse. IMMUNOGENETICS , 51 (4-5) 373 - 382.

Stein, H; Foss, HD; Dürkop, H; Marafioti, T; Delsol, G; Pulford, K; Pileri, S; (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood , 96 (12) pp. 3681-3695.

Stein, K; Hummel, M; Korbjuhn, P; Foss, HD; Anagnostopoulos, I; Marafioti, T; Stein, H; (2000) [Monocytic B-cells represent a new cell population that is mainly recruited from unmutated polyconal naive B-cells]. Verh Dtsch Ges Pathol , 84 pp. 151-152.

Stein, RC; Waterfield, MD; (2000) PI3-kinase inhibition: a target for drug development? Mol Med Today , 6 (9) pp. 347-357.

Stine, JT; Wood, C; Hill, M; Epp, A; Raport, CJ; Schweickart, VL; Endo, Y; (2000) KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. BLOOD , 95 (4) 1151 - 1157.

Stoeber, K; Williams, GH; (2000) A biochemical approach to cancer screening and diagnosis using antibodies against proteins that regulate DNA replication. In: Hospital Healthcare Europe 2000/2001. Campden Publishing Limited: London, UK.

Swerdlow, AJ; Barber, JA; Hudson, GV; Cunningham, D; Gupta, RK; Hancock, BW; Horwich, A; (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J CLIN ONCOL , 18 (3) 498 - 509.

T

Teixeira, R; Papatheodoridis, GV; Sabin, C; Davies, S; Dhillon, AP; Dagher, L; Pastacaldi, S; (2000) Progression of liver fibrosis in patients with recurrent hepatitis C after orthotopic liver transplantation. Hepatology , 32 258A-.

Teixeira, R; Pastacaldi, S; Davies, S; Dhillon, AP; Emery, VC; Rolles, K; Davidson, B; (2000) The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation. TRANSPLANTATION , 70 (10) 1454 - 1458.

Thomas, HD; Lind, MJ; Ford, J; Bleehen, N; Calvert, AH; Boddy, AV; (2000) Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours. CANCER CHEMOTH PHARM , 45 (4) 284 - 290.

Tipping, AJ; Mathew, CG; (2000) Erythropoiesis: Current Clinical Practice: Advances in the Genetics and Biology of Fanconi Anaemia. Hematology , 5 (1) pp. 1-13.

Torkar, M; Haude, A; Milne, S; Beck, S; Trowsdale, J; Wilson, MJ; (2000) Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7-kbp deletion. EUR J IMMUNOL , 30 (12) 3655 - 3662.

Towers, G; Bock, M; Martin, S; Takeuchi, Y; Stoye, JP; Danos, O; (2000) A conserved mechanism of retrovirus restriction in mammals. P NATL ACAD SCI USA , 97 (22) 12295 - 12299.

Tripodis, N; Palmer, S; Phillips, S; Milne, S; Beck, S; Ragoussis, J; (2000) Construction of a high-resolution 2.5-Mb transcript map of the human 6p21.2-6p21.3 region immediately centromeric of the major histocompatibility complex. GENOME RES , 10 (4) 454 - 472.

Tsuzuki, S; Towatari, M; Saito, H; Enver, T; (2000) Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein. MOLECULAR AND CELLULAR BIOLOGY , 20 (17) pp. 6276-6286. 10.1128/MCB.20.17.6276-6286.2000.

ten Dam, GB; Zilch, CF; Wallace, D; Wieringa, B; Beverley, PCL; Poels, LG; Screaton, GR; (2000) Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J IMMUNOL , 164 (10) 5287 - 5295.

V

Vanhaesebroeck, B; Alessi, DR; (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J , 346 Pt pp. 561-576.

Vaurs-Barrière, C; Penault-Llorca, F; Laplace-Marieze, V; Presneau, N; Maugard, CM; Fiche, M; Hardouin, A; (2000) Low frequency of microsatellite instability in BRCA1 mutated breast tumours. J Med Genet , 37 (10) E32-.

Verfuerth, S; Peggs, K; Vyas, P; Barnett, L; O'Reilly, RJ; Mackinnon, S; (2000) Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. BLOOD , 95 (12) 3990 - 3995.

Volpi, EV; Chevret, E; Jones, T; Vatcheva, R; Williamson, J; Beck, S; Campbell, RD; (2000) Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci , 113 ( pp. 1565-1576.

W

Wald, NJ; Hackshaw, AK; (2000) Advances in antenatal screening for Down Syndrome. In: UNSPECIFIED (563 - 580). BAILLIERE TINDALL

Wald, NJ; Hackshaw, AK; Cuckle, HS; (2000) Maternal serum alphafetoprotein screening for open neural tube defects: revised statistical parameters. BRIT J OBSTET GYNAEC , 107 (2) 296 - 298.

Wald, NJ; Hackshaw, AK; George, LM; (2000) Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome. J MED SCREEN , 7 (2) 74 - 77.

Wald, NJ; Hackshaw, AK; Huttly, W; (2000) Screening for Down's syndrome - Serum screening programmes are effective and safe. BRIT MED J , 321 (7263) 763 - 764.

Wald, NJ; Hackshaw, AK; Watt, H; (2000) Nuchal translucency and trisomy 18. PRENATAL DIAG , 20 (4) 353 - 354.

Wanless, IR; Sweeney, G; Dhillon, AP; Guido, M; Piga, A; Galanello, R; DeSanctis, V; (2000) Absence of deferiprone-induced hepatic fibrosis: A multi-center study. BLOOD , 96 (11) 606A - +.

Watts, MJ; Ings, SJ; Flynn, M; Dodds, D; Goldstone, AH; Linch, DC; (2000) Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. BRIT J HAEMATOL , 111 (1) 287 - 291.

Watts, MJ; Ings, SJ; Leverett, D; MacMillan, A; Devereux, S; Goldstone, AH; Linch, DC; (2000) ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients. BRIT J CANCER , 82 (2) 278 - 282.

Weiss, R; Boshoff, C; (2000) Addressing controversies over Kaposi's sarcoma. J NATL CANCER I , 92 (9) 677 - 679.

Westbury, C; Hines, F; Hawkes, E; Ashley, S; Brada, M; (2000) Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol , 54 (2) pp. 109-116.

Westbury, C; Vini, L; Fisher, C; Harmer, C; (2000) Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Thyroid , 10 (2) pp. 171-176. 10.1089/thy.2000.10.171.

Whitby, D; Luppi, M; Sabin, C; Barozzi, P; Di Biase, AR; Balli, F; Cucci, F; (2000) Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. BRIT J CANCER , 82 (3) 702 - 704.

White, AW; Almassy, R; Calvert, AH; Curtin, NJ; Griffin, RJ; Hostomsky, Z; Maegley, K; (2000) Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J MED CHEM , 43 (22) 4084 - 4097. 10.1021/jm000950v.

Whitely, W; Tariq, A; Peters, B; Kocjan, G; Miller, RF; (2000) Pyrexia of undetermined origin in the era of HAART. Sex Transm Infect , 76 (6) pp. 484-488.

Wilson, MJ; Torkar, M; Haude, A; Milne, S; Jones, T; Sheer, D; Beck, S; (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. P NATL ACAD SCI USA , 97 (9) 4778 - 4783.

Wittke, B; Ensor, H; Chung, J; Birnbock, H; Lausecker, B; Ertel, SI; Mackie, IJ; (2000) Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. BRIT J CLIN PHARMACO , 49 (3) 231 - 239.

Y

Yaguchi, H; Yoshida, M; Ding, GR; Shingu, K; Miyakoshi, J; (2000) Increased chromatid-type chromosomal aberrations in mouse m5S cells exposed to power-line frequency magnetic fields. Int J Radiat Biol , 76 (12) pp. 1677-1684.

Yee, TT; Griffioen, A; Sabin, CA; Dusheiko, G; Lee, CA; (2000) The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. GUT , 47 (6) 845 - 851.

Z

Zago, A; Bourboulia, D; Viana, MC; Collandre, H; Dietze, R; Boshoff, C; Keller, R; (2000) Seroprevalence of human herpesvirus 8 and its association with Kaposi sarcoma in Brazil. SEX TRANSM DIS , 27 (8) 468 - 472.

Zhong, S; Salomoni, P; Pandolfi, PP; (2000) The transcriptional role of PML and the nuclear body. NAT CELL BIOL , 2 (5) E85 - E90.

Ziegler, A; Ehlers, A; Forbes, S; Trowsdale, J; Volz, A; Younger, R; Beck, S; (2000) Polymorphisms in olfactory receptor genes: A cautionary note. HUM IMMUNOL , 61 (12) 1281 - 1284.

This list was generated on Sun Nov 20 06:19:21 2016 GMT.